Merrimack Pharmaceuticals appoints CFO
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Essential IR Insights Newsletter - February 2023
Merrimack Pharmaceuticals Inc. appointed Jean Franchi CFO of the company, effective Aug. 21.
Franchi most recently served as CFO of Dimension Therapeutics Inc.
The company reported in May that Yasir Al-Wakeel, who had served as CFO since August 2015, was leaving the company.
